Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Carson PE"" wg kryterium: Wszystkie pola


Tytuł :
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.
Autorzy :
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA.
Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA.
Fiuzat M; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Filippatos G; University of Cyprus Medical School, Shakolas Educational Center for Clinical Medicine, Nicosia, Cyprus.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, TN, USA.
Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Ambardekar AV; Division of Cardiology, University of Colorado, Aurora, CO, USA.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC, USA.
Jacob R; Patient Representative, Dublin, OH, USA.
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital, Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, MA, USA.
Konstam MA; The CardioVascular Center of Tufts Medical Center, Boston, MA, USA.
Krucoff MW; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Lewis EF; Division of Cardiovascular Medicine, Stanford University, Palo Alto, CA, USA.
Piccini JP; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Stockbridge N; United States Food and Drug Administration, Silver Spring, MD, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA, USA.
Unger EF; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Zeitler EP; Dartmouth-Hitchcock Medical Center and The Dartmouth Institute, Lebanon, NH, USA.
Anker SD; Division of Cardiology and Metabolism, Department of Cardiology, Berlin-Brandenburg Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA, USA.; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2020 Dec; Vol. 22 (12), pp. 2175-2186. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Heart Failure*/diagnosis
Heart Failure*/epidemiology
Heart Failure*/etiology
Heart Failure*/therapy
Terminology as Topic*
Clinical Trials as Topic/*standards
Cardiac Resynchronization Therapy ; Cardiovascular Agents/therapeutic use ; Comorbidity ; Consensus ; Defibrillators, Implantable ; Diagnostic Techniques, Cardiovascular/standards ; Electric Countershock/instrumentation ; Endpoint Determination/standards ; Europe ; Hospitalization ; Humans ; Patient Reported Outcome Measures ; Quality of Life ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction.
Autorzy :
Shen L; Department of Medicine, Hangzhou Normal University, Hangzhou, 310003, China.; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Anand IS; Department of Medicine, University of Minnesota Medical School and VA Medical Center, Minneapolis, USA.
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC, USA.
Desai AS; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Granger CB; Duke Clinical Research Institute, Duke University, Durham, NC, USA.
Køber L; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Western University, London, ON, Canada.
Pfeffer MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
Zile MR; Medical University of South Carolina and RHJ Department of Veterans Administration Medical Center, Charleston, USA.
McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK. .
Pokaż więcej
Źródło :
Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2021 Aug; Vol. 110 (8), pp. 1234-1248. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory.
Autorzy :
Bhatt AS; Cardiology Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA.
Lindenfeld J; Cardiology Division, Vanderbilt University, Nashville, Tennessee, USA.
Bristow M; Division of Cardiology, University of Colorado, Aurora, Colorado, USA.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Felker GM; Duke Clinical Research Institute and Division of Cardiology, Duke University, Durham, North Carolina, USA.
Fonarow GC; Department of Internal Medicine, University of California-Los Angeles, Los Angeles, California, USA.
Greene SJ; Duke Clinical Research Institute and Division of Cardiology, Duke University, Durham, North Carolina, USA.
Psotka MA; Inova Heart and Vascular Institute, Falls Church, Virginia.
Solomon SD; Cardiology Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Stockbridge N; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California, USA.
Vaduganathan M; Cardiology Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Wittes J; Statistics Collaborative, Washington, DC, USA.
Fiuzat M; Duke Clinical Research Institute and Division of Cardiology, Duke University, Durham, North Carolina, USA.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia.
Butler J; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA. Electronic address: .
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2021 Jan; Vol. 9 (1), pp. 1-12. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium.
Autorzy :
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA. Electronic address: .
Psotka MA; Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
Fiuzat M; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.
Filippatos G; University of Cyprus Medical School, Shakolas Educational Center for Clinical Medicine, Nicosia, Cyprus.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee, USA.
Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ambardekar AV; Division of Cardiology, University of Colorado, Aurora, Colorado, USA.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Jacob R; Patient Representative, Dublin, Ohio, USA.
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital, Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, Massachusetts, USA.
Konstam MA; The CardioVascular Center of Tufts Medical Center, Boston, Massachusetts, USA.
Krucoff MW; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.
Lewis EF; Division of Cardiovascular Medicine, Stanford University, Palo Alto, California, USA.
Piccini JP; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Stockbridge N; United States Food and Drug Administration, Silver Spring, Maryland, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California, USA.
Unger EF; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Zeitler EP; Dartmouth-Hitchcock Medical Center and The Dartmouth Institute, Lebanon, New Hampshire, USA.
Anker SD; Division of Cardiology and Metabolism, Department of Cardiology, Berlin-Brandenburg Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia, USA; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2020 Dec; Vol. 8 (12), pp. 961-972. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2.
Autorzy :
Loungani RS; Division of Cardiology and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, California, USA.
Metra M; Cardiology, ASST Civil Hospitals, and Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Allen LA; Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Butler J; Department of Medicine, University of Mississippi, Jackson, Mississippi, USA.
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC, USA.
Chen CW; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Cotter G; Momentum Research, Durham, North Carolina, USA.
Davison BA; Momentum Research, Durham, North Carolina, USA.
Eapen ZJ; Anthem Incorporated, Indianapolis, Indiana, USA.
Filippatos GS; School of Medicine, University of Cyprus, Nicosia, Cyprus, Greece; Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Gimpelewicz C; Novartis Pharma AG, Basel, Switzerland.
Greenberg B; University of California San Diego Health, Cardiovascular Institute, La Jolla, California, USA.
Holbro T; Novartis Pharma AG, Basel, Switzerland.
Januzzi JL Jr; Division of Cardiology, Department of Medicine, Harvard Medical School, and Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, Massachusetts, USA.
Lanfear DE; Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
Pang PS; Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Piña IL; Division of Cardiology, Wayne State University, Detroit, Michigan, USA.
Ponikowski P; Department of Cardiology, Wroclaw Medical University, Wroclaw, Poland.
Miller AB; Department of Cardiology, University of Florida, Jacksonville, Florida, USA.
Voors AA; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.
Felker GM; Division of Cardiology and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: .
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2020 Dec; Vol. 8 (12), pp. 999-1008. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel.
Autorzy :
Psotka MA; Inova Heart and Vascular Institute, Falls Church, Virginia. Electronic address: https://twitter.com/mpsotka.
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio. Electronic address: .
Fiuzat M; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina. Electronic address: https://twitter.com/mfiuzat.
Filippatos G; University of Cyprus Medical School, Shakolas Educational Center for Clinical Medicine, Nicosia, Cyprus.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee.
Ahmad T; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.
Bhatt AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Cleland JGF; Robertson Institute of Biostatistics and Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom.
Felker GM; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina.
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital and Baim Institute for Clinical Research, Boston, Massachusetts.
Kitzman DW; Sections on Cardiovascular Medicine and Geriatrics, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Leifer ES; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
Lewis EF; Division of Cardiovascular Medicine, Stanford University, Palo Alto, California.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Mentz RJ; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
Stockbridge N; United States Food and Drug Administration, Silver Spring, Maryland.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California-San Francisco, San Francisco, California. Electronic address: https://twitter.com/jteerlinkmd.
Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
Vardeny O; Pharmacy Practice Division, Minneapolis VA Center for Care Delivery and Outcomes Research and University of Minnesota, Minneapolis, Minnesota.
Whellan DJ; Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Wittes J; Statistics Collaborative, Washington, DC.
Anker SD; Division of Cardiology and Metabolism, Department of Cardiology, Berlin-Brandenburg Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia; Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina. Electronic address: https://twitter.com/coconnormd.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2020 Nov 17; Vol. 76 (20), pp. 2368-2378.
Typ publikacji :
Consensus Development Conference; Journal Article; Review
MeSH Terms :
Clinical Trials as Topic*
Coronavirus Infections*
Pandemics*
Pneumonia, Viral*
COVID-19 ; Endpoint Determination ; Humans ; Socioeconomic Factors ; Statistics as Topic
Czasopismo naukowe
Tytuł :
Covariate adjusted reanalysis of the I-Preserve trial.
Autorzy :
Ferreira JP; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.; National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), University of Lorraine, Regional University Hospital of Nancy, Nancy, France.
Dewan P; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Lorenzo-Almorós A; Department of Internal Medicine. Renal, Vascular and Diabetes Laboratory, Instituto de Investigaciones Sanitarias Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
Duarte K; National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), University of Lorraine, Regional University Hospital of Nancy, Nancy, France.
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.
Carson PE; Cardiovascular Division, Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC, USA.
McKelvie R; Department of Medicine, Western University, London, ON, Canada.
Komajda M; Service de Cardiologie, Hôpital Saint Joseph, Paris, France.
Zile M; Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA.
Zannad F; National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), University of Lorraine, Regional University Hospital of Nancy, Nancy, France.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK. .
Pokaż więcej
Źródło :
Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2020 Nov; Vol. 109 (11), pp. 1358-1365. Date of Electronic Publication: 2020 Mar 25.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Angiotensin Receptor Antagonists/*therapeutic use
Heart Failure/*drug therapy
Stroke Volume/*physiology
Aged ; Female ; Heart Failure/physiopathology ; Hospitalization/trends ; Humans ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Tytuł :
Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study.
Autorzy :
Wiegn P; Department of Clinical Cardiac Electrophysiology, Dallas VA Medical Center, TX (P.W.).
Chan R; Chan Heart Rhythm Institute, Mesa, AZ (R.C.).
Jost C; Southwest Cardiovascular Associates, Mesa, AZ (C.J.).
Saville BR; Berry Consultants, Austin, TX (B.R.S.).
Parise H; Independent Consultant, Las Vegas, NV (H.P.).
Prutchi D; Impulse Dynamics, Mt. Laurel, New Jersey (D.P.).
Carson PE; Department of Medicine, Washington VA Medical Center, DC (P.E.C.).
Stagg A
Goldsmith RL; Exercise Physiology Laboratory, Columbia University Medical Center, New York (R.L.G.).
Burkhoff D; Cardiovascular Research Foundation, New York (D.B.).
Pokaż więcej
Źródło :
Circulation. Heart failure [Circ Heart Fail] 2020 Apr; Vol. 13 (4), pp. e006512. Date of Electronic Publication: 2020 Apr 08.
Typ publikacji :
Clinical Study; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiac Pacing, Artificial*/adverse effects
Myocardial Contraction*
Pacemaker, Artificial*
Stroke Volume*
Ventricular Function, Left*
Heart Failure/*therapy
Aged ; Equipment Design ; Female ; Heart Failure/diagnosis ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Recovery of Function ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
Autorzy :
Butler J; Department of Medicine, University of Mississippi Medical Center, Jackson (J.B.).
Packer M; Baylor University Medical Center, Dallas, TX (M.P.).
Greene SJ; Duke Clinical Research Institute, Durham, NC (S.J.G., M.F., K.J.A., A.F.H.).; Division of Cardiology, Duke University School of Medicine, Durham, NC (S.J.G., A.F.H.).
Fiuzat M; Duke Clinical Research Institute, Durham, NC (S.J.G., M.F., K.J.A., A.F.H.).
Anker SD; Berlin-Brandenburg Center for Regenerative Therapies, Germany (S.D.A.).; Department of Cardiology, German Center for Cardiovascular Research partner site Berlin, Charite Universitatsmedizin Berlin (S.D.A.).
Anstrom KJ; Duke Clinical Research Institute, Durham, NC (S.J.G., M.F., K.J.A., A.F.H.).
Carson PE; Cardiovascular Division, Department of Cardiology, Washington Veterans Affairs Medical Center (P.E.C.).
Cooper LB; Inova Heart and Vascular Institute, Falls Church, VA (L.B.C., C.M.O.).
Fonarow GC; Ahmanson-UCLA Cardiomyopathy Center, University of California Los Angeles (G.C.F.).
Hernandez AF; Duke Clinical Research Institute, Durham, NC (S.J.G., M.F., K.J.A., A.F.H.).; Division of Cardiology, Duke University School of Medicine, Durham, NC (S.J.G., A.F.H.).
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital and Baim Institute for Clinical Research, Boston (J.L.J.).
Jessup M; American Heart Association, Dallas, TX (M.J.).
Kalyani RR; Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD (R.R.K.).
Kaul S; Cedars-Sinai Medical Center, Los Angeles, CA (S.K.).
Kosiborod M; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City (M.K.).; The George Institute for Global Health, University of New South Wales, Sydney, Australia (M.K.).
Lindenfeld J; Vanderbilt Heart and Vascular Institute, Nashville, TN (J.L.).
McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.).
Sabatine MS; TIMI Study Group (M.S.S.), Brigham and Women's Hospital, Boston, MA.; Division of Cardiovascular Medicine (M.S.S., S.D.S., M.V.), Brigham and Women's Hospital, Boston, MA.
Solomon SD; Division of Cardiovascular Medicine (M.S.S., S.D.S., M.V.), Brigham and Women's Hospital, Boston, MA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center, CA (J.R.T.).; School of Medicine, University of California, San Francisco (J.R.T.).
Vaduganathan M; Division of Cardiovascular Medicine (M.S.S., S.D.S., M.V.), Brigham and Women's Hospital, Boston, MA.
Yancy CW; Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL (C.W.Y.).
Stockbridge N; Division of Cardiovascular and Renal Products, United States Food and Drug Administration, Silver Spring, MD (N.S.).
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA (L.B.C., C.M.O.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2019 Dec 17; Vol. 140 (25), pp. 2108-2118. Date of Electronic Publication: 2019 Dec 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Clinical Trials as Topic/*methods
Diabetes Mellitus, Type 2/*drug therapy
Heart Failure/*drug therapy
Sodium-Glucose Transporter 2 Inhibitors/*therapeutic use
Cardiovascular Diseases/blood ; Cardiovascular Diseases/drug therapy ; Cardiovascular Diseases/epidemiology ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/epidemiology ; Endpoint Determination ; Heart Failure/blood ; Heart Failure/epidemiology ; Humans ; Research Report/standards ; Sodium-Glucose Transporter 2/blood ; Sodium-Glucose Transporter 2 Inhibitors/pharmacology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
Autorzy :
Dewan P; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Rørth R; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).; Rigshospitalet Copenhagen University Hospital, Denmark (R.R., L.K.).
Raparelli V; Center for Outcomes Research and Evaluation, Research Institute, McGill University Health Centre, Montreal, Quebec, Canada (V.R.).; Department of Experimental Medicine, Sapienza University of Rome, Italy (V.R.).
Campbell RT; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Shen L; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Anand IS; VA Medical Center, University of Minnesota, MN (I.S.A.).
Carson PE; Georgetown University, Washington DC Veterans Affairs Medical Center (P.E.C.).
Desai AS; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., M.A.P., S.D.S.).
Granger CB; Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.).
Køber L; Rigshospitalet Copenhagen University Hospital, Denmark (R.R., L.K.).
Komajda M; Department of Cardiology, Hospital Saint Joseph, France (M.K.).
McKelvie RS; St. Joseph's Healthcare Centre, Western University, London, ON, Canada (R.S.M.).
O'Meara E; Montreal Heart Institute and Université de Montreal, Quebec, Canada (E.O.).
Pfeffer MA; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., M.A.P., S.D.S.).
Pitt B; Department of Internal Medicine-Cardiology, University of Michigan School of Medicine, Ann Arbor (B.P.).
Solomon SD; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., M.A.P., S.D.S.).
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden (K.S.).; National Heart and Lung Institute, Imperial College, London (K.S.).
Zile MR; Ralph H. Johnson Veterans Administration Medical Center, Medical University of South Carolina, Charleston, SC (M.R.Z.).
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.D., R.R., R.T.C., L.S., P.S.J., M.C.P., J.J.V.M.).
Pokaż więcej
Źródło :
Circulation. Heart failure [Circ Heart Fail] 2019 Dec; Vol. 12 (12), pp. e006539. Date of Electronic Publication: 2019 Dec 09.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Health Status Disparities*
Stroke Volume*
Ventricular Function, Left*
Heart Failure/*physiopathology
Adult ; Aged ; Cause of Death ; Comorbidity ; Death, Sudden, Cardiac/epidemiology ; Disease Progression ; Evidence-Based Medicine ; Female ; Heart Failure/diagnosis ; Heart Failure/mortality ; Heart Failure/therapy ; Hospitalization ; Humans ; Male ; Middle Aged ; Prognosis ; Quality of Life ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Sex Factors ; Time Factors
Czasopismo naukowe
Tytuł :
Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development.
Autorzy :
Psotka MA; Inova Heart and Vascular Institute, Falls Church, Virginia. Electronic address: .
Fiuzat M; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Kao DP; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
Cerkvenik J; Medtronic Inc., Minneapolis, Minnesota.
Schaber DE; Medtronic Inc., Minneapolis, Minnesota.
Verta P; Edwards Lifesciences, Irvine, California.
Kazmierski RT; U.S. Food and Drug Administration, Silver Spring, Maryland.
Shinnar M; U.S. Food and Drug Administration, Silver Spring, Maryland.
Stockbridge N; U.S. Food and Drug Administration, Silver Spring, Maryland.
Unger EF; U.S. Food and Drug Administration, Silver Spring, Maryland.
Zuckerman B; U.S. Food and Drug Administration, Silver Spring, Maryland.
Butler J; Department of Medicine, University of Mississippi, Jackson, Mississippi.
Felker GM; Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Konstam MA; CardioVascular Center of Tufts Medical Center, Boston, Massachusetts.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia.
Abraham WT; Departments of Medicine, Physiology, and Cell Biology, Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Ohio State University, Columbus, Ohio.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2019 Nov; Vol. 7 (11), pp. 913-921. Date of Electronic Publication: 2019 Aug 07.
Typ publikacji :
Journal Article
MeSH Terms :
Forms as Topic*
Medical Records*
Heart Failure/*diagnosis
Heart Failure/*therapy
Humans
Czasopismo naukowe
Tytuł :
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
Autorzy :
Tromp J; National Heart Centre Singapore and Duke-NUS Medical School, Singapore; Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Shen L; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Anand IS; Department of Medicine, University of Minnesota Medical School and VA Medical Center, Minneapolis, Minnesota.
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC.
Desai AS; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Granger CB; Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Western University, London, Ontario, Canada.
Pfeffer MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Køber L; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
Swedberg K; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg and National Heart and Lung Institute, Imperial College, London, United Kingdom.
Zile MR; Medical University of South Carolina and Ralph H. Johnston Veterans Administration Medical Center, Charleston, South Carolina.
Pitt B; Department of Internal Medicine-Cardiology, University of Michigan School of Medicine, Ann Arbor, Michigan.
Lam CSP; National Heart Centre Singapore and Duke-NUS Medical School, Singapore; Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2019 Aug 06; Vol. 74 (5), pp. 601-612.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Benzimidazoles/*therapeutic use
Biphenyl Compounds/*therapeutic use
Heart Failure/*physiopathology
Irbesartan/*therapeutic use
Mineralocorticoid Receptor Antagonists/*therapeutic use
Stroke Volume/*physiology
Tetrazoles/*therapeutic use
Ventricular Function, Left/*physiology
Age Factors ; Aged ; Aged, 80 and over ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Echocardiography ; Female ; Global Health ; Heart Failure/drug therapy ; Heart Failure/epidemiology ; Humans ; Male ; Middle Aged ; Morbidity/trends ; Prognosis ; Survival Rate/trends ; Systole
Czasopismo naukowe
Tytuł :
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
Autorzy :
Shen L; Department of Cardiology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Rørth R; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Cosmi D; Department of Cardiology, Hospital of Gubbio, Gubbio, Italy.
Kristensen SL; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Cosmi F; Department of Cardiology, Hospital of Cortona, Cortona, Italy.
Latini R; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Køber L; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Anand IS; Department of Medicine, University of Minnesota Medical School and VA Medical Center, Minneapolis, MN, USA.
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC, USA.
Granger CB; Duke Clinical Research Institute, Duke University, Durham, NC, USA.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Western University, London, Ontario, Canada.
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Staszewsky L; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; National Heart and Lung Institute, Imperial College London, London, UK.
Huynh T; McGill Health University Center, Division of Cardiology, Montreal, Quebec, Canada.
Zile MR; Medical University of South Carolina and Ralph H. Johnston Veterans Administration Medical Center, Charleston, SC, USA.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2019 Aug; Vol. 21 (8), pp. 974-984. Date of Electronic Publication: 2019 Jul 04.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2/*drug therapy
Heart Failure/*physiopathology
Insulin/*therapeutic use
Stroke Volume/*physiology
Ventricular Function, Left/*physiology
Aged ; Cause of Death/trends ; Diabetes Mellitus, Type 2/complications ; Female ; Global Health ; Heart Failure/diagnosis ; Heart Failure/mortality ; Hospitalization/trends ; Humans ; Hypoglycemic Agents/therapeutic use ; Male ; Middle Aged ; Prognosis ; Quality of Life ; Survival Rate/trends
Czasopismo naukowe
Tytuł :
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Autorzy :
Shen L; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Petrie MC; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
Anand IS; Department of Medicine, University of Minnesota Medical School, and Veterans Affairs Medical Center, Minneapolis, Minnesota.
Carson PE; Cardiovascular Division, Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC.
Desai AS; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Granger CB; Division of Cardiovascular Medicine, Department of Internal Medicine, Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Department of Medicine, Western University, London, Ontario, Canada.
Pfeffer MA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Solomon SD; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Zile MR; Medical University of South Carolina, Charleston, South Carolina; Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina.
McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2019 May; Vol. 7 (5), pp. 418-427. Date of Electronic Publication: 2019 Apr 10.
Typ publikacji :
Journal Article
MeSH Terms :
Cardiac Pacing, Artificial/*statistics & numerical data
Heart Failure/*physiopathology
Hospitalization/*statistics & numerical data
Pacemaker, Artificial/*statistics & numerical data
Ventricular Dysfunction, Left/*physiopathology
Aged ; Aged, 80 and over ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Benzimidazoles/therapeutic use ; Cardiovascular Diseases/mortality ; Cause of Death ; Death, Sudden, Cardiac/epidemiology ; Female ; Heart Failure/drug therapy ; Humans ; Irbesartan/therapeutic use ; Male ; Middle Aged ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Mortality ; Prognosis ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Spironolactone/therapeutic use ; Stroke Volume ; Tetrazoles/therapeutic use
Czasopismo naukowe
Tytuł :
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
Autorzy :
Kristensen SL; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).; Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., R.R., L.K.).
Mogensen UM; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).; Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., R.R., L.K.).
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).
Rørth R; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).; Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., R.R., L.K.).
Anand IS; Department of Medicine, University of Minnesota Medical School and Veterans Affairs Medical Center, Minneapolis (I.S.A.).
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, DC (P.E.C.).
Desai AS; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.S.D., M.A.P., S.D.S.).
Pitt B; Division of Cardiology, Department of Medicine, University of Michigan School of Medicine, Ann Arbor (B.P.).
Pfeffer MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.S.D., M.A.P., S.D.S.).
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (A.S.D., M.A.P., S.D.S.).
Zile MR; Medical University of South Carolina and Ralph H. Johnston Veterans Affairs Medical Center, Charleston (M.R.Z.).
Køber L; Department of Cardiology, Rigshospitalet University Hospital, Copenhagen, Denmark (S.L.K., U.M.M., R.R., L.K.).
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.L.K., U.M.M., P.S.J., R.R., J.J.V.M.).
Pokaż więcej
Źródło :
Circulation. Heart failure [Circ Heart Fail] 2019 Mar; Vol. 12 (3), pp. e005766.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Atrial Fibrillation/*blood
Atrial Fibrillation/*physiopathology
Heart Failure/*blood
Heart Failure/*physiopathology
Natriuretic Peptide, Brain/*blood
Peptide Fragments/*blood
Aged ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Randomized Controlled Trials as Topic ; Risk Assessment ; Stroke Volume/physiology
Czasopismo naukowe
Tytuł :
Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy.
Autorzy :
Ambrosy AP; Division of Cardiology, The Permanente Medical Group, San Francisco, CA, USA.; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Stevens SR; Department of Biostatistics and Bioinformatics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Al-Khalidi HR; Department of Biostatistics and Bioinformatics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
Rouleau JL; Research Center, Montreal Heart Institute, Montreal, Quebec, Canada.
Bouabdallaoui N; Research Center, Montreal Heart Institute, Montreal, Quebec, Canada.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC, USA.
Adlbrecht C; 4th Medical Department, Karl Landsteiner Institute for Cardiovascular and Critical Care Research, Hietzing Hospital, Vienna, Austria.
Cleland JGF; Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, Scotland, UK.
Dabrowski R; 2nd Department of Coronary Artery Disease, Institute of Cardiology, Warsaw, Poland.
Golba KS; Department of Electrocardiology and Heart Failure, School of Health Sciences, Medical University of Silesia, Katowice, Poland.
Pina IL; Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USA.
Sueta CA; Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Roy A; Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
Sopko G; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Bonow RO; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Velazquez EJ; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Pokaż więcej
Corporate Authors :
STICH Trial Investigators
Źródło :
European journal of heart failure [Eur J Heart Fail] 2019 Mar; Vol. 21 (3), pp. 373-381. Date of Electronic Publication: 2019 Jan 30.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Cardiovascular Agents*/administration & dosage
Cardiovascular Agents*/adverse effects
Coronary Artery Bypass*/adverse effects
Coronary Artery Bypass*/methods
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/surgery
Cost of Illness*
Heart Failure*/mortality
Heart Failure*/physiopathology
Heart Failure*/psychology
Heart Failure*/therapy
Myocardial Ischemia/*complications
Cardiomyopathies/etiology ; Cardiomyopathies/therapy ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Quality of Life ; Severity of Illness Index ; Stroke Volume ; Survival Analysis ; Walk Test/methods
Czasopismo naukowe
Tytuł :
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation.
Autorzy :
Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio. Electronic address: .
Kuck KH; Department of Cardiology, ASKLEPIOS Klinik St. Georg, Hamburg, Germany.
Goldsmith RL; Exercise Physiology Laboratory, Columbia University Medical Center, New York, New York.
Lindenfeld J; Department of Heart Failure and Transplant, Vanderbilt Heart, Nashville, Tennessee.
Reddy VY; Department of Cardiac Arrhythmia Services, The Mount Sinai Hospital, New York, New York.
Carson PE; Medical Intensive Care Unit, Washington VA Medical Center, Washington, DC.
Mann DL; Cardiovascular Division, Medicine, Washington University School of Medicine, St. Louis, Missouri.
Saville B; Berry Consultants, Austin, Texas.
Parise H; R. P. Chiacchierini Consulting, Gaithersburg, Maryland.
Chan R; Chan Heart Rhythm Institute, Mesa, Arizona.
Wiegn P; Department of Clinical Cardiac Electrophysiology, Dallas VA Medical Center, Dallas, Texas.
Hastings JL; Department of Clinical Cardiac Electrophysiology, Dallas VA Medical Center, Dallas, Texas.
Kaplan AJ; Department of Clinical Cardiac Electrophysiology, Cardiovascular Associates of Mesa, Mesa, Arizona.
Edelmann F; Department of Cardiology and Pneumology, Universität Göttingen, Göttingen, Germany.
Luthje L; Department of Cardiology and Pneumology, Universität Göttingen, Göttingen, Germany.
Kahwash R; Department of Heart Failure & Transplantation, The Ohio State University Heart and Vascular Center, Columbus, Ohio.
Tomassoni GF; Department of Clinical Cardiac Electrophysiology, Baptist Health Lexington, Lexington, Kentucky.
Gutterman DD; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin.
Stagg A; Clinical Trials, Impulse Dynamics, Orangeburg, New York.
Burkhoff D; Cardiovascular Research Foundation, New York, New York.
Hasenfuß G; Heart Center of Göttingen, University Medical Center Göttingen, Göttingen, Germany.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2018 Oct; Vol. 6 (10), pp. 874-883. Date of Electronic Publication: 2018 May 10.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Myocardial Contraction*
Electric Stimulation/*methods
Heart Failure/*therapy
Electric Stimulation/adverse effects ; Electric Stimulation/instrumentation ; Electrodes, Implanted ; Exercise Test ; Exercise Tolerance ; Female ; Heart Failure/mortality ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Quality of Life ; Stroke Volume/physiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Trying to Make Progress on Survival in a Complicated Area: Sudden Death in HFpEF.
Autorzy :
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC. Electronic address: peter.carson@med.va.gov.
Pokaż więcej
Źródło :
JACC. Heart failure [JACC Heart Fail] 2018 Aug; Vol. 6 (8), pp. 662-664. Date of Electronic Publication: 2018 Jun 06.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Heart Failure*
Death, Sudden, Cardiac ; Humans ; Stroke Volume ; Ventricular Function, Left
Opinia redakcyjna
Tytuł :
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
Autorzy :
Taylor, Walter R. J. (AUTHOR)
Kim, Saorin (AUTHOR)
Kheng, Sim (AUTHOR)
Muth, Sinoun (AUTHOR)
Tor, Pety (AUTHOR)
Christophel, Eva (AUTHOR)
Mukaka, Mavuto (AUTHOR)
Kerleguer, Alexandra (AUTHOR)
Luzzatto, Lucio (AUTHOR)
Baird, J. Kevin (AUTHOR)
Menard, Didier (AUTHOR)
Pokaż więcej
Źródło :
PLoS Neglected Tropical Diseases. 9/8/2021, Vol. 15 Issue 9, p1-13. 13p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies